Tyler Santiago Ventura
Associate
Overview
Tyler S. Ventura is a healthcare regulatory attorney in Holland & Knight's Nashville office. Mr. Ventura advises clients on a range of regulatory compliance issues, including healthcare fraud and abuse, Medicare and Medicaid reimbursement, licensing and changes in ownership.
Mr. Ventura's practice also encompasses day-to-day operational matters involving healthcare providers and organizations.
While in law school, Mr. Ventura worked as a law clerk within the Office of the General Counsel at the U.S. Department of Commerce.
Before his legal career, Mr. Ventura worked as a health insurance specialist with the Centers for Medicare & Medicaid Services (CMS) Center for Consumer Information and Insurance Oversight (CCIIO).
Representative Experience
- Advised a private equity-backed network of integrated eye care practices in its acquisition of the nonclinical assets of a retina-focused ophthalmology practice
- Represented a private equity firm with a focus on investing in high-growth healthcare technology and services companies in its recapitalization of a provider of analytics, software and services supporting pharmacy care management
- Provided counsel to a private equity-backed network of integrated eye care practices in its acquisition of certain nonclinical assets of a regional ophthalmology practice
- Advised a private equity-backed network of integrated eye care practices in its acquisition of the assets of a management services organization (MSO) supporting ophthalmology practices
- Represented a private equity-backed network of urgent care and primary care clinics in its acquisition of an urgent care provider
- Represented a healthcare technology and services company in its acquisition of a value-based care business from a large healthcare enterprise
Credentials
- The University of North Carolina at Chapel Hill School of Law, J.D.
- The University of North Carolina at Chapel Hill, B.A., Peace, War & Defense and History
- Tennessee
- American Health Law Association (AHLA), 2025-2026